Mycobacterium marinum-infected zebrafish are used to study tuberculosis pathogenesis, as well as for antitubercular drug discovery. the small size of zebrafish larvae coupled with their optical transparency allows for rapid analysis of bacterial burdens and host survival in response to genetic and pharmacological manipulations of both mycobacteria and host. automated fluorescence microscopy and automated plate fluorimetry (apF) are coupled with facile husbandry to facilitate large-scale, repeated analysis of individual infected fish. Both methods allow for in vivo screening of chemical libraries, requiring only 0.1 mmol of drug per fish to assess efficacy; they also permit a more detailed evaluation of the individual stages of tuberculosis pathogenesis. Here we describe a 16-h protocol spanning 22 d, in which zebrafish larvae are infected via the two primary injection sites, the hindbrain ventricle and caudal vein; this is followed by the high-throughput evaluation of pathogenesis and antimicrobial efficacy.
IntroDuctIon
Tuberculosis remains a grave problem through much of the world, with an increase in both drug-sensitive and drug-resistant disease. There is an urgent need for a deeper understanding of its immunopathogenesis and for the identification of new drugs. Traditionally, the mouse, guinea pig and rabbit have been used for studies of mycobacterial pathogenesis 1 . Each has its advantages and disadvantages. The mouse is replete with immunological and genetic tools, whereas the guinea pig and rabbit mimic the pathology of human tuberculosis more closely. More recently, primates have been used for tuberculosis studies; although primates mirror human tuberculosis the most closely, this model presents additional ethical and cost concerns 1 . The zebrafish is a natural host to M. marinum, a pathogen of ectotherms that is the closest genetic relative of the M. tuberculosis organism complex 1 . Adult zebrafish develop tuberculosis-like disease with pathology that is strikingly similar to that of humans.
We have developed the zebrafish larva as a model in order to study in unprecedented detail the early events of mycobacterial pathogenesis: macrophage recruitment to the site of infection, phagocytosis of the bacteria and the transit of infected macrophages back into deeper tissues in which granuloma formation occurs [2] [3] [4] . By using this model, we have revisited and overturned long-standing dogmas about mycobacterial pathogenesis, e.g., the role of the macrophage and the granuloma [3] [4] [5] [6] . We have identified a role for excess inflammation as a driver of pathogenesis and have validated these findings in humans 5, 7 . Finally, we have developed the zebrafish as a model for antitubercular drug discovery, wherein both traditional antimicrobials and new classes of host-targeting antimicrobials can be identified 8, 9 .
Zebrafish are increasingly being used to study the pathogenesis of a variety of other bacterial, viral and fungal infections [10] [11] [12] [13] [14] [15] [16] [17] , of host interactions with commensal bacteria 18 and of noninfectious diseases such as cancer 19, 20 . The protocol we describe here should be broadly adaptable to the study of other infectious and inflammatory conditions.
Experimental design
Infection experiments are initiated by choosing the ideal fluorescent strain, which is then cultured and processed to yield a single-cell preparation. Adult zebrafish are spawned as previously described 21 to produce zebrafish larvae, which are then infected with M. marinum by microinjection into either the hindbrain ventricle at 30 h post fertilization (h.p.f.) or the caudal vein at 30-48 h.p.f. After hindbrain injection, the number of recruited macrophages to the hindbrain ventricle is enumerated by differential interference contrast (DIC) microscopy and compared with control, i.e., larvae that have been hindbrain-injected with vehicle alone. The recent engineering of zebrafish lines with fluorescent macrophages should allow for this assay to be performed by fluorescence microscopy as well 22 . After systemic infection via microinjection into the caudal vein, intracellular bacterial burden can be assessed by direct counting of bacteria per macrophage. In addition, overall bacterial burden of whole larvae can be quantified by high-throughput fluorescence microscopy followed by fluorescence quantification of images via fluorescent pixel count (FPC) or by APF. If desired, infection burden and larval survival can be used as an output for antimicrobial compound efficacy by the addition of compounds directly to fish water. Teal  pTEC17  399  456  54,400   Wasabi  pTEC15  493  509  56,000   mOrange2  pTEC16  549  565  34,800   tdTomato  pTEC27  554  581  95,220   tdKatushka2 pTEC22  588  633  49,025   mKate2  pTEC20  588  635  15,300   E2-Crimson  pTEC19  611  646  28,980 Fluorescent bacterial strains. Initial fluorescence-based work using M. marinum was limited to the basic green and red fluorescent proteins EGFPmut3 and dsRed. To take advantage of the improved brightness and spectral options available, as well as to enhance the ability to use multiple combinations of bacterial and host fluorescent reporters, a variety of newly available fluorescent proteins were cloned into the constitutively expressed mycobacterial pmsp12 vector ( Table 1 ). For simple experiments in which only a single fluor is required, tdTomato provides optimal brightness with low larval autofluorescence. For APF, which is less sensitive than fluorescence microscopy, the bright, far-red tdKatushka2 fluorescent protein is required to maximize fluorescent signal while minimizing autofluorescence of larval tissue.
Single-cell preparations. Because M. marinum cultures contain a mixture of clumps of various sizes, as well as single cells, processing of culture is required to produce a homogenous, quantitatively controlled preparation for consistent microinjections and infection dosing. Previously, mycobacterial cultures were grown to mid-log phase and then repeatedly passaged through a 27-gauge needle to reduce the size and abundance of bacterial aggregates, while also generating single-cell bacteria 23 . Although this produced a more homogenized preparation of bacteria, aggregates of variable size were still present, making exact enumeration and control of infection dose impossible. Alternatively, passage of culture through a 5-µm filter resulted in the isolation of single-cell mycobacteria, thus allowing for exact enumeration and infection dosing; however, loss of bacteria during filtration resulted in low yields. Thus, both methods were combined: syringe passaging to generate larger numbers of single cells, followed by filtration to isolate them (Fig. 1) . In addition, normal growth medium lacking Tween, 7H9OADC, was used for suspension of bacteria to avoid potential bacterial cell death in PBS. Tests comparing the survival of larvae injected with 7H9OADC or PBS showed that neither had any detrimental effect on larval health. Finally, the procedure was scaled up and followed by storage of prepared aliquots at − 80 °C to eliminate the time and labor required for repeated preparation of bacterial preps for each experiment, while also improving the consistency of infection dose from experiment to experiment 24 .
Injection sites. Although many anatomical structures can be targeted for infection, the two primary injection sites are the hindbrain ventricle and the caudal vein (Fig. 2) . The hindbrain ventricle is normally devoid of macrophages and has thus been the standard for assessing the recruitment of macrophages to the site of infection 2, 3, 8 or the ability of chemoattractant molecules to stimulate chemotaxis 9 . Infection via the caudal vein is used for producing systemic infections and analyzing multiple infection outcomes, such as bacteria per macrophage 7, 25 , granuloma formation 5, 6 , overall infection burden 5, 26 and drug efficacy 24, 26 . Because of changes in larval physiology during development, including shrinking of the hindbrain ventricle and increased rigidity of the larval epithelium making penetration of larvae difficult, the optimal time for injection into the hindbrain ventricle is 30 h.p.f., whereas the caudal vein may be injected between 30 and 48 h.p.f. Hindbrain injections were traditionally performed using a standard microprobe 23 , which serves as a simple L-shaped prod for pushing and pulling the larva into position. Although the standard microprobe has been in use for several years, its simple design combined with the curved shape of the larval yolk sac, the anatomical structure leveraged for injecting into the hindbrain, makes it difficult to maintain a secure grasp of the larva. Because of this, hindbrain injections were a tedious and error-prone process for even those with a high degree of user skill and hand coordination. To eliminate this difficulty and to increase the speed and efficiency in which hindbrain injections could be performed, a new microprobe titled the VAMP (Vacuum-Assisted MicroProbe) was developed ( Fig. 3 and Supplementary Videos 1and 2) .
Caudal vein injections have been the standard method for producing systemic infections, which allow for the enumeration of bacteria within individual macrophages 7, 25 ; they also allow for fluorescencebased measurements of overall bacterial burden for comparing virulence between various host 6, 27 and bacterial strains 5, 7, 26 for assessing the efficacy of drug and other small-molecule treatment 24, 26 .
Fluorescence quantification of bacterial burden. Infection burdens have been traditionally determined by enumeration of colony-forming units (c.f.u.) after lysis of infected larvae and plating on 7H10 agar plates 23 . This method has the following limitations: it allows for only a single, terminal time point for the collection of data; it is not very sensitive, as a large proportion of bacteria are killed by the lysis buffer; and this killing disproportionately affects certain bacterial mutants relative to the wild type. Therefore, we developed two methods for rapid, serial quantification of bacterial burden in live larvae via fluorescence: FPC and APF. For both methods, larvae are transferred to 96-well optical-bottom plates, one larva per well.
To reversibly anesthetize the larvae to prevent movement during the imaging process, while avoiding the labor-intensive addition and removal of chemical anesthetics, larval cryo-anesthesia was developed, in which the 96-well plate is incubated on ice 24 . Cryo-anesthetized larvae are then rapidly imaged using an inverted fluorescence microscope with an automated stage. The resulting images are then quantified for fluorescence by FPC using a custom macro developed for the open-source image analysis software, ImageJ. APF can be used for a more rapid and facile, albeit less-sensitive readout of bacterial fluorescence. Cryo-anesthesia is not required; the 96-well plate is simply loaded into a fluorescence plate reader and bacterial fluorescence is measured in the far-red channel. In addition, the natural spike in green autofluorescence after larval death can be used as a simultaneous automated readout of larval death. Thus, both efficacy and toxicity of drugs and small molecules can be measured 24 .
In summary, by combining larval housing, microscopy and fluorescence quantification into a 96-well-plate format, timeconsuming and labor-intensive handling steps are eliminated, while also allowing for small, one-time administration of compounds that can affect infection 22, 24 .
Assessment of individual infection steps.
For a more detailed understanding of pathogenesis, macrophage microbicidal capacity can be assessed by enumerating bacteria within individual macrophages by fluorescence microscopy. This capacity is influenced by the host's ability to kill bacteria and the bacterium's ability to resist being killed. Therefore, both bacterial and host mutants affect it 7, 24, 25, 28 .
In addition, because various bacterial and host mutants affect not only the overall bacterial burden but also the ability to form granulomas, the hallmark pathological structure of tuberculosis, quantification of infection focus size 6 can be performed; tools for this are included in the FPC software. • Wide-bore P1000 pipette tip Cut a standard P1000 pipette tip ~0.5 cm from the tip using a razor blade. Microinjection station setup Set up the micromanipulator station as shown in Supplementary Fig. 1 . On the micromanipulator, angle the needle holder downward to ~30° from the horizontal plane.
MaterIals

REAGENTS
proceDure single-cell preparation of M. marinum • tIMInG 6 h 1| Inoculate 10 ml of 7H9C from a − 80 °C strain collection in a 50-ml tissue culture flask, and then incubate it at 33 °C for ~8-10 d.  crItIcal step If multiple bacterial strains are to be compared, they should all be prepared simultaneously by using the same batch of medium.
2|
Measure the optical density at 600 nm (OD 600 ) and then inoculate 50 ml of 7H9C in a 250-ml tissue culture flask to a final concentration of 0.1 OD 600 . Incubate the flask at 33 °C for ~5-7 d until the OD 600 reaches 0.5-1.0.
3|
Pellet the culture by centrifugation for 15 min at 4,000g at room temperature. Remove the supernatant by decanting or pipetting.
4|
Resuspend the pellet in 1 ml of 7H9OADC, and then aliquot 200 µl into a 1.5-ml microcentrifuge tube. Transfer further 200 µl aliquots into four additional microcentrifuge tubes.
5| By using a 27-gauge tuberculin syringe, aspirate and eject each 200 µl of resuspended bacteria ten times (supplementary Video 3). ! cautIon To prevent injury and self-infection, handle infected needles carefully.
6| Add 1 ml of 7H9OADC to each 200-µl aliquot; mix each aliquot by inversion or briefly vortex and then centrifuge it at 100g for 1 min.
7|
Collect and transfer 1 ml of the supernatant to a 15-ml centrifuge tube.
8|
Repeat Steps 5-7 with the remaining 200 µl twice more. The final collected syringed culture will be 15 ml.
9| Pass 5 ml of processed culture through a sterile 5-µm filter to isolate single-cell bacteria. Repeat this twice more for the remaining 10 ml, by using a new filter for each 5 ml of processed culture.
10|
Transfer the filtrate to microcentrifuge tubes and then centrifuge the filtrate at 20,000g for 5 min at room temperature. Discard the supernatant.
11|
Resuspend and combine all pellets in a total volume of 200 µl of 7H9OADC.
12| Dilute 1 µl of processed bacteria in 999 µl of dH 2 O, and then spot 1 µl to a slide and allow it to dry.
13|
Enumerate the number of fluorescent bacteria by fluorescence microscopy using a ×20 objective. At this dilution, 100 fluorescent bacteria on the slide corresponds to a single-cell preparation of 100 fluorescent bacteria per nl, which will yield an infection dose of ~100 bacteria.
14|
If necessary, dilute the single-cell preparation with 7H9OADC to the desired final concentration, typically 100-500 fluorescent bacteria per nl. For recommended concentrations, see table 2.
15| Prepare 5-µl aliquots and store them at − 80 °C.  pause poInt Frozen aliquots can be stored at − 80 °C indefinitely.
16|
To verify bacterial concentration, thaw and serially dilute a single-cell prep in PBS, and then plate it onto 7H10 for enumeration of c.f.u.
Infection of zebrafish larvae via hindbrain or caudal vein injections 17|
Incubate zebrafish larvae at 28 °C.
18|
Transfer the larvae to FWPTU between 8 and 24 h.p.f. to prevent pigment formation. Maintain the larvae in the presence of PTU for the duration of the experiment.
19|
Dechorionate the larvae within 30 h.p.f. by grasping the chorion at two points using a pair of jeweler's forceps, and then carefully tearing the chorion open.  crItIcal step To avoid injuring the larvae, do not allow the forceps or the chorion itself to make contact with the larvae. 20| Anesthetize 30-48-h.p.f. larvae by incubation in FWPTU + tricaine for 3 min. Maintain the larvae in anesthetized state until the injection procedure is complete.
21| By using a wide-bore Pasteur pipette, transfer 10-20 larvae to a depression slide. By using the microprobe, group the larvae together on the side nearest you. ? trouBlesHootInG (a) Infection of zebrafish larvae via hindbrain injections (i) By using the VAMP, grab each larva by the yolk for injection directly into the hindbrain, or by the tail for injection into the hindbrain via the forebrain.  crItIcal step Thumb pressure over the side port is directly related to the degree of occlusion of the port, and thus to suction pressure. Use gentle thumb pressure to avoid excessive suction, which can cause injury to the larva, including yolk rupture and aspiration of the larva entirely. (ii) Gently push the larva into the tip of the needle until it just pierces the desired ventricle of the brain.
22|
 crItIcal step Use caution to avoid overpenetration and injury to the surrounding tissues. (iii) Depress the foot pedal to inject.  crItIcal step Infection dose is dependent on the concentration of the single-cell prep and the volume injected, whereas the injection volume is dependent on the microinjection needle bore size, injection pressure and time.
Because the microinjection needle bore size is variable depending on slight variations in where the needle is broken, injection pressure and time will need to be adjusted to produce the desired injection volume. Typically, injection pressure and time settings range from 250 to 500 hPa and 0.2 to 0.4 s. To control for consistent injection volume from larva to larva, and from experiment to experiment, the visual indicator dye should fill ~50-100% of the hindbrain ventricle. Alternatively, the user may decide to use a larger injection volume that fills both the hindbrain and forebrain ventricles. To adjust the infection dose, users typically adjust the concentration of bacteria in the single-cell prep while keeping the injection volume constant. To verify injection volume, one injection volume can be injected into mineral oil on a hemocytometer and the diameter of the droplet can be measured (supplementary Fig. 2b) . To verify infection dose, spot 100 µl of PBS onto 7H10 and then inject one injection volume into the PBS spot and spread it. Incubate the plate for 8-10 d and then enumerate c.f.u. (iv) After injection, remove the larva from the needle and move it to the far end of the slide. (v) Repeat injection (Step 26A(i-iv)) with up to 30 larvae per needle.
 crItIcal step Despite maintaining a constant injection volume, the number of c.f.u. per injection can decrease over time. To reduce variance of infection dose, limit the number of injected larvae to 30-100 per needle. (vi) When this step is complete, transfer injected larvae to a small Petri plate containing 10 ml of FWPTU without tricaine and resume incubation at 28 °C.  crItIcal step An equal number of larvae should be injected with a microinjection needle loaded with 5 µl of 7H9OADC combined with 0.25 µl of phenol red stock as a negative control.
(B) Infection of zebrafish larvae via caudal vein injections (i) Raise the needle upward, away from the bottom of the depression slide.
(ii) By using the microprobe, position the larva so that the caudal vein region is directly below the tip of the needle.
(iii) Lower the needle until it makes contact with the caudal vein region of the larva. When contact is made, the larva will rotate slightly along its dorsoventral axis. (iv) Gently push the larva into the tip of needle until it just pierces the caudal vein region. (ii) By using either an ×20 or ×40 objective and a DIC filter, slowly scan through the z axis of the hindbrain region, counting the number of macrophages observed (Fig. 4a,b and supplementary Video 6). Macrophage morphology is observed as round or irregular, sometimes with pseudopodia. Although different types of phagocytes can be distinguished by the use of fluorescently labeled transgenic larvae, or by in situ or antibody staining of fixed larvae, we find that DIC microscopy is sufficient for the enumeration of macrophages, as we have not observed other cell types within the hindbrain within 36 h.p.f. in response to mycobacterial infection. (B) Bacteria per macrophage via fluorescence microscopy (i) Anesthetize the larvae at 2-5 days after infection in FWPTU + tricaine and then transfer them to a 0.17-mm glassbottom plate. To avoid counting bias, blind groups. (ii) By using either an ×20 or ×40 objective, scan the region between the yolk extension and the tip of the tail (Fig. 4c) (i) Prepare a half-area 96-well plate by pipetting 100 µl of dH 2 O to the interwell space using a multichannel pipette. The addition of dH 2 O to the interwell space reduces evaporation within wells, and also increases the thermal mass to lengthen the duration in which larvae remain cryo-anesthetized. (ii) Transfer larvae to the prepared 96-well plate, one larva per well, each in 200 µl of FWPTU (without tricaine) using a wide-bore P1000 pipette tip. Include 3-5 uninfected larvae for threshold determination during image analysis. If compound testing is desired, 2 µl of compound in dH 2 O or 100% DMSO can be added to each well, followed by transferring the larva in 198 µl of FWPTU. Alternatively, drug-containing FWPTU can be prepared first, and larvae can be added to it and then transferred to each well in 200 µl of FWPTU containing the drug. (iii) Cryo-anesthetize the larvae by incubating them on ice for 10 min.
 crItIcal step Larvae must be thoroughly cryo-anesthetized to ensure that the larvae remain immobile during the imaging procedure.
(iv) Image each well via inverted ×2 fluorescence microscopy.  crItIcal step Imaging should be performed on an inverted microscope fitted with an automated stage calibrated to rapidly image each well. If imaging is performed at room temperature, the entire plate should be imaged within 10 min to ensure that larvae remain cryo-anesthetized. (j) Detailed analysis at 4 days after treatment, the last time point before any death has occurred, allows for the best resolution between treatment groups. (k) Survival data generated by APF measurement of green autofluorescence provide additional information regarding drug efficacy.
(xii) Follow the prompts: locate the folder of images to be measured and then enter the threshold as previously determined. Hit 'OK' to perform FPC analysis. (xiii) Copy and paste the data from the summary window to Excel, Prism or the desired software for data analysis. The first, third and fourth columns, 'Slice', 'Total Area' and 'Average Size', correspond with the image name, FPC value and average infection focus size for each individual larva. (D) Quantification of bacterial burden via automated plate fluorimetry (i) Transfer the larvae to 96-well plates, one larva per well, each in 200 µl of FWPTU (without tricaine), by using a wide-bore P1000 pipette tip. Include three to five uninfected larvae, which will be used to provide a baseline reading for normalization. (ii) Transfer the plate to a fluorescence plate reader and measure far-red fluorescence using a 12-point 4 × 4 beam pattern to maximize the measured surface area per well. For appropriate fluorescence filters, see EQUIPMENT. (iii) If survival data are desired, measure green autofluorescence. Larvae with relative fluorescent unit (r.f.u.) readings above 3,000 are scored as dead.  crItIcal step The optimal threshold may vary on different fluorescence plate readers, and should initially be experimentally determined by comparing green autofluorescence and mortality for 10-20 larvae daily for 14 d. Mortality is assessed by the absence of a heartbeat by stereomicroscopy. We have found that an experimentally determined optimal threshold of 3,000 consistently predicts mortality from experiment to experiment. (iv) After APF, return the larval plate to 28 °C. The larval plate can be incubated at 28 °C for up to 14 d, with APF repeated daily as desired.
? trouBlesHootInG Troubleshooting advice can be found in table 3. Step 27, analysis of infection: 4 h
antIcIpateD results
Single-cell preparation from 50 ml of culture of M. marinum is typically sufficient to yield 100-200 aliquots of 5 × 10 7 to 5 × 10 8 c.f.u. ml − 1 . However, in some cases the yield is lower, requiring a compromise in either final concentration or the number of aliquots. Microinjection of M. marinum into the hindbrain ventricle results in a marked recruitment of macrophages within 6 h.p.i. (Fig. 4a,b) , as compared with mock larvae injected with medium lacking bacteria. Caudal vein injections with both the wild-type and the virulence-attenuated ∆erp mutant M. marinum produce systemic infections in which the attenuation can be quantified either as a reduction of intracellular bacterial burden per macrophage (Fig. 4f) or as an overall reduction of infection level as determined by fluorescence microscopy and FPC of images (Fig. 4g,h) . Figure 4i -k shows results from compound screening performed with wild type-infected larvae housed in 96-well plates in the presence of 400 µM antibiotic. Infection level can be quantified daily by APF (Fig. 4i) ; the optimal time point for comparison as late as possible but before larval death is 4 days after treatment for this experiment (Fig. 4j) . Survival data can be generated from green autofluorescence, and it is complementary to infection level (Fig. 4k) . For confirmation of survival status, the presence or absence of a heartbeat can be determined by microscopy. 
